Deciphering Gynecological Pathologies in Women With Acne and Alopecia: An Imaging Experience

    May 2023 in “ PubMed ”
    Dr. Basharat Mumin, Inzamam Wani, Shahbaz Qazi, Sheikh Riaz Rasool, Irfan Robbani, Mudasir Hamid, Mohd. Ashraf Ganai
    Image of study
    TLDR Women with acne and hair loss, even if they have regular periods, often have polycystic ovary syndrome.
    The study evaluated ovarian morphology and the prevalence of polycystic ovarian morphology (PCOM) in females aged 21 to 45 with acne and/or androgenic alopecia. Out of 115 patients, 28 (24.34%) had isolated androgenic alopecia, 54 (46.95%) had combined acne and alopecia, and 33 had isolated acne. Among those with isolated acne, 17 (51.5%) had PCOM. Among those with isolated alopecia, 16 (57.1%) had PCOM. Among those with combined acne and alopecia, 32 (59.3%) had PCOM. The study concluded that women with dermatological manifestations like acne and androgenic alopecia, even with regular menstruation, have a high prevalence of PCOS.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 3 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 5 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

      community How does hair loss and recovery work?

      in Chat  12 upvotes 2 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.
      The story of RU58841/ PSK3841

      community The story of RU58841/ PSK3841

      in Research  622 upvotes 3 months ago
      RU58841, a potential hair loss treatment, was not commercialized due to marketability issues and lack of long-term safety data. Concerns about its formulation and delivery methods further complicate its use.

      community Received Kintor’s KX-826 Today

      in Product  84 upvotes 3 months ago
      A user received Kintor’s KX-826/Pyrilutamide and shared initial impressions, noting concerns about the product's labeling and marketing. Other users discussed the legitimacy of the product, its effectiveness, and compared it to other treatments like Minoxidil and Finasteride.

    Related Research

    4 / 4 results